← Back to Search

Other

BAY 59-8862 for Non-Hodgkin's Lymphoma

Phase 2

Waitlist Available

Research Sponsored by Theradex

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Histologically confirmed aggressive refractory non-Hodgkin's lymphoma (NHL) of specified classifications for which chemotherapy is deemed appropriate

No active clinically serious infections

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is testing a new drug to treat people with a certain type of cancer that has not responded to other treatments.

Who is the study for?

This trial is for adults with aggressive non-Hodgkin's lymphoma that hasn't responded to previous treatments. Participants must have a certain type of measurable cancer, be in fairly good health, and not have had certain other cancers or treatments recently. They should expect to live at least 12 weeks and agree to use barrier contraception.Check my eligibility

What is being tested?

The trial is testing the effectiveness of BAY 59-8862, a chemotherapy drug, on patients with refractory non-Hodgkin's lymphoma. It aims to see if this drug can stop cancer cells from growing or cause them to die when other treatments haven't worked.See study design

What are the potential side effects?

While specific side effects for BAY 59-8862 are not listed here, common side effects of chemotherapy drugs include nausea, vomiting, hair loss, fatigue, increased risk of infection due to low blood cell counts, and potential damage to organs like the heart or liver.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My lymphoma is aggressive and not responding to treatment, and I need chemotherapy.

Select...

I do not have any serious infections right now.

Select...

I do not have severe numbness or pain in my hands or feet.

Select...

I have never had a seizure.

Select...

I have no other cancer except for certain allowed types.

Select...

I am 18 years old or older.

Select...

My previous cancer treatment didn't work, or my cancer returned within 6 months.

Select...

I am able to get out of my bed or chair and move around.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

0 / 8Eligibility criteria met

Find a Location

Who is running the clinical trial?

TheradexLead Sponsor

33 Previous Clinical Trials

1,562 Total Patients Enrolled

3 Trials studying Lymphoma

80 Patients Enrolled for Lymphoma

Rasim Ahmet Gucalp, MDStudy ChairMontefiore Medical Center

1 Previous Clinical Trials

35 Total Patients Enrolled

1 Trials studying Lymphoma

35 Patients Enrolled for Lymphoma

Media Library

BAY 59-8862 (Other) Clinical Trial Eligibility Overview. Trial Name: NCT00039156 — Phase 2

Lymphoma Clinical Trial 2023: BAY 59-8862 Highlights & Side Effects. Trial Name: NCT00039156 — Phase 2

BAY 59-8862 (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00039156 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has this medication received FDA authorization?

"While there is some evidence that this intervention is safe, it has not been proven effective yet. Therefore, it received a safety score of 2."

Answered by AI

Could you provide a number for how many hospitals are part of this study?

"Currently, there are 15 sites across the country enrolling patients for this clinical trial. If you are interested in participating, it is recommended that you try and select a location close to reduce travel burden. Sites can be found in Memphis, Chicago, Bronx and other locations."

Answered by AI

Are patients needed for this research project at the moment?

"This specific clinical trial, as indicated on the government-run website clinicaltrials.gov, is not currently looking for more patients. The study was created on 1/1/2002 and last updated on 7/23/2008. Although this particular trial is not taking any more volunteers, there are 1,792 other trials that are still enrolling patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

2002. "BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00039156.

All > Childhood Leukemia > Lymphoma